Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 19,792 results that match your search.19,792 results
  • IP Nav’s Erich Spangenberg’s predictions for 2015 will make gloomy reading for IP practitioners – he says patent reform will pass, IPRs will become even more popular, patent lawsuits will fall, GAAP write-downs are on their way and big IP law firms will make cuts
  • On January 6 Alibaba announced a revamp of its TaoProtect online policing system which applies to its online sales portals www.taobao.com and www.tmall.com. Both are Chinese-language trade platforms, the prior ostensibly C2C and the latter B2C.
  • Lex Machina’s Hatch-Waxman/ANDA Report reveals a spike in case filing, as well as the biggest participants and law firms in ANDA patent litigation
  • On March 9 2018, Cambodia officially deposited its instrument of accession to the Geneva Act of the Lisbon Agreement on Appellations of Origin and Geographical Indications, becoming the first nation to join the Geneva Act.
  • The Supreme Court has agreed for a second time to hear Mayo v Prometheus, a case that tests the application of the In re Bilski ruling on patentable subject matter to diagnostic methods. Prometheus' patent specifically covers methods of determining the proper dosage of thiopurine drugs in patients. Following its decision in Bilski last year, the High Court immediately granted certiorari in the case and vacated and remanded the decision back to the Federal Circuit to reconsider the facts in light of Bilski. But in December last year, the Federal Circuit decided in favour of Prometheus for the second time, with little departure from its original reasoning. Mayo is now arguing that the Federal Circuit's decision is inconsistent with the Supreme Court's earlier precedents, with the reasoning of the three dissenting Justices in LabCorp v Metabolite and with Bilski. All eyes are on Justice Stephen Breyer, the remaining dissenter in LabCorp, who dubbed the diagnostic method patent at issue in that case "abstract" and "no more than an instruction to read some numbers in light of medical knowledge".
  • AOL’s $1.06 billion patent deal with Microsoft comes as no surprise following other recent blockbuster deals - but what will Microsoft do with the patents, and who will be next?
  • Most trade mark practitioners heading to Dallas for the INTA Annual Meeting next week will be aiming to learn a little bit, pick up some business cards and see something of the city. But for one attendee, there will be a lot of thinking to do
  • The Global Intellectual Property Centre is out with its 2nd International IP Index, and its findings may raise a few eyebrows
  • Fernando dos Santos, ARIPO director general, has explained the office's $5.8 million IT project in an interview with Managing IP – although lawyers in the country say enforcement is a much greater priority
  • Michael Geist, law professor, University of Ottawa, and director of e-commerce law, Goodmans LLP, Toronto